Objective: The objective of our study was to determine how well CT predicts the need for laparotomy in hemodynamically stable patients with penetrating abdominal injury.

Materials And Methods: We reviewed MEDLINE articles published from January 1994 through June 2008. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy were calculated for each source and collectively using a meta-analysis.

Results: Of 180 relevant studies, five were included in the meta-analysis. Pooled weighted estimates of sensitivity, specificity, NPV, PPV, and accuracy were 94.90%, 95.38%, 98.62%, 84.51%, and 94.70%, respectively.

Conclusion: CT in patients with penetrating abdominal trauma has high sensitivity, specificity, NPV, and accuracy, but has lower PPV in determining the need for laparotomy. It follows that CT is an indispensable tool in predicting the need for laparotomy in these patients but still has room for improvement.

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.08.1927DOI Listing

Publication Analysis

Top Keywords

patients penetrating
12
penetrating abdominal
12
sensitivity specificity
12
laparotomy hemodynamically
8
hemodynamically stable
8
stable patients
8
ppv accuracy
8
specificity npv
8
well predict
4
laparotomy
4

Similar Publications

Background: Penetrating cardiac trauma is an entity with high pre and intrahospital mortality due to complications such as cardiac tamponade and massive hemothorax. A ventricular septal defect (VSD) occurs in 1-5% of cases and can present early or late. The management strategy for VSD resulting from penetrating cardiac trauma is uncertain.

View Article and Find Full Text PDF

Transdermal drug delivery (TDD) represents a transformative paradigm in drug administration, offering advantages such as controlled drug release, enhanced patient adherence, and circumvention of hepatic first-pass metabolism. Despite these benefits, the inherent barrier function of the skin, primarily attributed to the stratum corneum, remains a significant impediment to the efficient permeation of therapeutic agents. Recent advancements have focused on macromolecular-assisted permeation enhancers, including carbohydrates, lipids, amino acids, nucleic acids, and cell-penetrating peptides, which modulate skin permeability by transiently altering its structural integrity.

View Article and Find Full Text PDF

Central Nervous System Metastases in Breast Cancer.

Curr Treat Options Oncol

January 2025

Breast Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Breast cancer metastasizing to the central nervous system (CNS) encompasses two distinct entities: brain metastases involving the cerebral parenchyma and infiltration of the leptomeningeal space, i.e., leptomeningeal disease.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

IMDEA Nanociencia, Madrid, Spain.

Background: About half of the patients suffering from Alzheimer's disease (AD) display sleeping disorders. Disruptions in the central circadian clock (CC), located in the brain, accelerate AD pathogenesis, making the CC a promising target. In preclinical trials, this strategy have shown efficacy but clinical results are inconsistent.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Manifold Bio, Boston, MA, USA.

Background: Drug delivery to the central nervous system has long been hindered by the restrictive properties of the blood-brain barrier (BBB). Recent advances have highlighted the ability of certain antibody "shuttles'' to traverse the BBB and enhance the delivery of diverse therapeutic payloads. However the true potential of this approach remains underexplored and is limited by traditional in vitro screening platforms that fail to capture the complexities of in vivo biology.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!